Literature DB >> 24725323

Surgical management of pterygium.

Ben J Janson1, Shameema Sikder2.   

Abstract

Pterygia are noncancerous growths of conjunctiva that may require surgical removal because of discomfort, cosmesis, or obstruction of vision. Pterygia often recur after excision. The major goal of pterygium treatment is avoiding recurrence, but complication rates and cosmetic results are also considered. Despite the number of techniques available, there is no consensus on the best procedure. Even the best techniques carry risk of recurrence and complications. In this review, different surgical techniques, graft attachment methods, and adjuvant therapies in current use are discussed. Also discussed are newer techniques that early studies have shown to be promising, but require more investigation before becoming a recommended treatment. The review is intended to provide an overview of the current research to inform surgeons with regard to their decisions and aid researchers in hypothesis generation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adjuvant therapy; conjunctival disease; graft attachment; pterygium; recurrence

Mesh:

Year:  2014        PMID: 24725323     DOI: 10.1016/j.jtos.2014.01.001

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  26 in total

Review 1.  Mitomycin C in pterygium treatment.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Milton Ruiz Alves; Roger Chammas; Paulo Schor
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

2.  Autologous simple conjunctival epithelial transplantation for primary pterygium.

Authors:  Emilio Pedrotti; Marina Bertolin; Adriano Fasolo; Erika Bonacci; Francesca Bosello; Diego Ponzin; Giorgio Marchini
Journal:  Int Ophthalmol       Date:  2022-05-25       Impact factor: 2.031

3.  c-FOS Expression Analysis in Pterygia Cell Spot Arrays.

Authors:  Stylianos Mastronikolis; Evangelos Tsiambas; Marina Pagkalou; Olga E Makri; Vasiliki K Thomopoulou; Dimitrios Peschos; Vasileios Ragos; Dimitrios Roukas; Constantinos D Georgakopoulos
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

4.  Acupoint Massage plus Recombinant Bovine Basic Fibroblast Growth Factor Ophthalmic Gel and Limbal Stem Cell Transplantation on Visual Quality, Corneal Refraction, and Aesthetic Outcome in Patients with Pterygium.

Authors:  Xiaoqin Zhang; Yu Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-14       Impact factor: 2.650

Review 5.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

Review 6.  Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis.

Authors:  Wen Zeng; Zengming Liu; Hanjun Dai; Ming Yan; Hong Luo; Min Ke; Xiaojun Cai
Journal:  BMC Ophthalmol       Date:  2017-11-25       Impact factor: 2.209

7.  Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia.

Authors:  Qianli Meng; Yaowu Qin; Monika Deshpande; Fabiana Kashiwabuchi; Murilo Rodrigues; Qiaozhi Lu; Hui Ren; Jennifer H Elisseeff; Gregg L Semenza; Silvia V Montaner; Akrit Sodhi
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

8.  Comparison of fibrin glue and Vicryl sutures in conjunctival autografting for pterygium surgery.

Authors:  Xiu Wang; Yan Zhang; Lei Zhou; Ruihua Wei; Lijie Dong
Journal:  Mol Vis       Date:  2017-04-19       Impact factor: 2.367

Review 9.  The use of dry amniotic membrane in pterygium surgery.

Authors:  Gelareh S Noureddin; Sonia N Yeung
Journal:  Clin Ophthalmol       Date:  2016-04-18

10.  Conjunctival Lymphangiogenesis Was Associated with the Degree of Aggression in Substantial Recurrent Pterygia.

Authors:  Wei Zhao; Tao Wang; Juan Deng; Lei Zhong; Weilan Huang; Shiqi Ling
Journal:  J Ophthalmol       Date:  2016-01-28       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.